The company reported revenue of $10.97 billion and earnings of $1.34 on a per-share and adjusted basis, compared to the ...

Abbott Laboratories’ ABT growth in the fourth quarter of 2024 can be attributed to strong improvement in global Core ...

ABT currently has a PEG ratio of 2.43. Another notable valuation metric for HAE is its P/B ratio of 4.28. Investors use the P/B ratio to look at a stock's market value versus its book value ...

This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. ABT currently has a PEG ratio of 2.43. Another notable ...

ABBOTT LABORATORIES (ABT) is a large-cap growth stock in the Medical Equipment & Supplies industry. The rating using this strategy is 68% based on the firm’s underlying fundamentals and the ...

Abbott Laboratories (NYSE:ABT – Get Free Report ... has an “overweight” rating on the healthcare product maker’s stock. Wells Fargo & Company‘s price target would suggest a potential ...

Abbott Laboratories’ ABT growth in the third quarter of 2024 can be attributed to strong sales recovery within the Nutrition business, driven by the robust sales performance of Ensure, ...

ABT currently has a PEG ratio of 2.68. Another notable valuation metric for PBH is its P/B ratio of 2.39. The P/B is a method of comparing a stock's market value to its book value, which is defined as ...